Sexual function in premenopausal women with breast cancer

Abstract Background: This cross-sectional study assessed Female Sexual Function Index (FSFI) scores in premenopausal women with breast cancer diagnosis. We aimed to determine variables that are associated with sexual dysfunction and if these thematic is being addressed by healthcare professionals.Methods: The FSFI questionnaire was administered to 199 premenopausal women 6 months after completing breast cancer initial treatment (surgery, radiation therapy or chemotherapy). A demographic questionnaire was administered. Scores were compared between sexually active women sub-groups. Questions, regarding FSFI acceptability and to find out if healthcare professionals are addressing these thematic were included.Results: The study included 199 women. Thirty-three were excluded from analysis because they declared no sexual activity in the 4 weeks before the survey. Ninety-seven women met the FSFI cutoff score for a sexual dysfunction. FSFI Scores were significantly lower in women treated with radiation therapy and in women treated with radical mastectomy and lumpectomy when compared with mastectomy with immediate reconstruction. One hundred and thirty-eight women were never or rarely questioned about their sexual health even though 71.2% reported feeling comfortable about sharing this problematic with doctors. Both sexually active and non-active women provided positive feedback about the FSFI.Conclusion: FSFI scores were compatible with sexual dysfunction in more than half of the sexually active women. Women treated with radiation therapy, radical mastectomy and lumpectomy had significant lower FSFI scores. With desirable acceptability, the FSFI is suitable for screening for sexual dysfunction in premenopausal women with